Company / Current Assets
Progyny Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$551.8M
FY2025
5-year range
$258.5M / $640.4M
FY2021-FY2025
Trend
+16.7%
vs FY2024
Sector context
#108 of 165
Health Care
What the data says
At $552M, Progyny's current assets ranks #108 of 165 in the Health Care sector. Declined from $640M to $552M over the past 2 years.
Based on SEC 10-K filings.
$552M in FY2025 with a 5-year CAGR of +23.7%.
Declined from $640M to $552M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +8.3%
- 5-Year CAGR
- +23.7%
- 10-Year CAGR
- -
Sector benchmark
#108 of 165 in Health CareTop 65% of 165This company $551.8M Sector average $5.2B
▼
-89.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.7%, indicating consistent growth.
- In FY2025, current assets increased 16.7% year-over-year.
- Ranks #108 out of 165 companies in the Health Care sector.
- Peak current assets was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $551.8M | +16.7% |
| FY2024 | $472.7M | -26.2% |
| FY2023 | $640.4M | +47.6% |
| FY2022 | $433.9M | +67.8% |
| FY2021 | $258.5M | +35.9% |
| FY2020 | $190.2M | +43.6% |
| FY2019 | $132.4M | +439.8% |
| FY2018 | $24.5M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026